AzTrials
AzTrials

Stretch MarksFRFNCT03931525

Effect of Radiofrecuency on Stretch Marks

A study testing Fractitional Radiofrecuency with Drug Delivery and Fractitional Radiofrecuency in people with Stretch Marks, run by Quiropraxia y Equilibrio at 1 site in Brazil.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

This study aims to explore the effects of fractional Radiofrecuency (RF), as well as demonstrate the performance of the new semi-ablative radiofrequency model in the treatment of stretch marks. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Stretch Marks
What is being tested?
Fractitional Radiofrecuency with Drug Delivery and Fractitional Radiofrecuency
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteBrazil
Study dates
1 Jun 2019to 1 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Women over 18 and not older than 45 years
  • Presence Gluteal and Abdominal Striae.
  • Stretch marks aesthetic discomfort

Who cannot join

  • Malignancy.
  • Metal implants or abdominal or pelvic stents
  • Presence of collagen diseases.
  • Alteration in the synthesis of proteins.
  • Alterations of the integrity of the skin such as burns, wounds, keloids, hypertrophic scars or dermatitis.
  • Intake of steroidal and nonsteroidal anti-inflammatory drugs.
Show all 11Show fewer
  • Hypocaloric diet indicated by nutritionist.
  • Do not agree with the intervention protocol.
  • Elimination Criteria
  • Non-tolerance of the intervention with electrotherapy that requires the suspension of treatment.
  • Non-completion of the evaluation protocol (Attendance at all scheduled sessions).

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Universidade Potiguar

    Natal, Lagoa Nova, 59056-000

Other trials in Brazil

About this study

Official title: Effect of Fractional Radiofrecuency Associated Cosmetology Derug Delivery in Treatment of Strech Marks

This study aims to explore the effects of fractional Radiofrecuency (RF), as well as demonstrate the performance of the new semi-ablative radiofrequency model in the treatment of stretch marks. This research is a randomized, controlled clinical trial where 32 female patients complaining of glutes and / or abdomen striations. The participants were divided into two equal groups, G1 and G2. G1 will be treated at 30-day intervals, and subdivided into 2 subgroups: G1A, 8 patients with striations in the abdomen; and G1B, 8 patients with gluteal striations. The G1A and G1B groups will be divided into 2 subgroups of 4 people each, where one group will be treated with Fractional RF associated to drug delivery, and the other group, with only Fractional RF, without the application of drug delivery. The same rule of subdivisions will occur in G2, G2A and G2B, however, the interval between applications will be every 15 days. The treatment area will be divided into a rectangle 10cm high by 10cm wide. For evaluation, the contralateral side will be used as a control, using Photogrammetry and histological analysis as a resource, which will be collected through the punch skin fragment of the infraumbilical and gluteal region, performed by a specialized physician.

Read the detailed description
  1. INTRODUCTION Stretch marks are characterized by common dermatological conditions, being aesthetically unpleasant, disturbing especially women of different age groups. Analyzing the histological aspect, they present as atrophic lesions that disperse collagen and elastic tissue, in addition to reducing the presence of skin cells such as keratinocytes, melanocytes and fibroblasts. It is noted that the striations may be distributed locally or numerously, disposed parallel to one another and perpendicular to the skin cleavage lines. At the beginning, the striae appear erythematous-violet, thin and may generate pruritus, characterizing its inflammatory phase. When the inflammatory phase passes, the striations develop into an atrophic condition, they acquire a whitish appearance, almost pearly, becoming wider, due to the rupture of elastic and collagen fibers. Dermatofunctional physiotherapy already has several resources to treat these effects, such as therapeutic ultrasound, cryolipolysis, radiofrequency, low intensity laser and high intensity focused ultrasound. RF heating is commonly used to cause shrinkage of dermal collagen and induce stimulation of fibroblast cells that produce a new collagen. Radiofrequency is a non-invasive treatment, which leads to better circulatory and nutrient supply, tissue hydration, increased oxygenation, acceleration of elimination of catabolites, lipolysis, contraction of the connective tissue promoting reorientation of collagen fibers and increase in as well as soft tissue regeneration, and is indicated for patients with mild to moderate skin flaccidity, to improve the facial and body contour, to attenuate furrows and ridges, to moderate retraction of the fibers, and to increase the thickness and density of the epithelial tissue. sub-mental area and neck and treatment of gynoid lipodystrophy, like all equipment of deep thermo therapy, causes a great cellular excitation, leading to an accentuated caloric expenditure, while we will be promoting an expressive improvement of localized fat or cellulite in the circulatory part promoting a important vasodilatation, but when there is fibrosis very early, rapid preheating with radiofrequency is recommended initially. Fractional RF is another possibility for the treatment of cutaneous aging. It is a procedure that emits waves that reach the deeper layers of the skin, generating energy and strong heat, but keeping the surface cooled and protected. the procedure reaches the depth of 100 microns, that is, it reaches the papillary dermis, where it causes ablation and coagulation of surrounding proteins by residual thermal damage. This both leads to contraction of existing collagen fibers and stimulates the formation of new fibers, making them more efficient in supporting the skin. After discovering the advantages of fractionation applied to some forms of light for skin rejuvenation, several other researches have been done, and today we have different types of laser, radiofrequency and infrared devices that use this property as a way to keep treatments safer and effective. The development of RF fractionation was then initiated. In the fractured form this feature can be used ablatively and sub ablatively, where tissues suffer less trauma. There is still a lot to be studied about this new therapeutic resource, and the literature on the subject is very scarce. For this reason, this research aims to elucidate and increase the knowledge about Fractional RF. Through histological analysis and other data, we seek to ensure and clarify the effects of Fractional Radiofrequency at the dermal and epidermal level.
  2. GENERAL OBJECTIVE: -Investigate the effects of Fractional Radiofrequency in the treatment of striae of the abdominal and gluteal regions associated or not with the active permeation (Drug Delivery).
  3. SPECIFIC OBJECTIVES:
  • Compare the effects of Fractional Radiofrequency on the dermal tissue in the abdominal and gluteal regions of women, associated or not with the drug permeation (Drug Delivery), through the histological analysis.
  • Demonstrate the performance of Fractional Radiofrequency equipment in the treatment of stretch marks in the abdominal and gluteal regions of women in different treatment periods (15 and 30 days), when or not associated with drug delivery.
  • Identify the performance of Fractional RF equipment in the treatment of stretch marks in abdominal and gluteal regions in different treatment periods (every 15 and 30 days).
  1. HYPOTHESES:
  • The application of Fractional Radiofrequency does not interfere in the treatment of stretch marks.
  • The application of Fractional Radiofrequency interferes in the treatment of stretch marks.
  • The permeation of assets associated with fractional RF interferes with the treatment of stretch marks.
  • Asset permeation associated with Fractional RF does not interfere with the treatment of stretch marks.
  1. METHODOLOGY 5.1 CHARACTERIZATION OF STUDY AND SAMPLE: The research is characterized as a randomized clinical trial in which 32 female volunteers will be selected, whose main complaint is the appearance of stretch marks in the abdominal area and gluteal areas. 5.2 LOCATION OF THE RESEARCH: The participats will be assisted in an outpatient dermatological and physiotherapy treatment appropriately structured for the proposed study, containing electrical network compatible with the fractional RF equipment used, an appropriate environmental cooling system for the proper functioning of the machine, and good hygiene and lighting conditions, according to the provisions of the local Sanitary Surveillance, will be in the clinic of physiotherapy, located at Av. Antônio Basílio - Lagoa Seca / Natal-RN owned by Dr. Eneida Carreiro. MATERIALS: Fractional RF Equipment, Artis model, manufactured by Tone Derm will be used. A tape measure of the brand Fiber, a scale of the mark Glicomed, a device of Plicometria and a device of ultrasonografia of high frequency (12MHz), a punch of procedure, camera of the mark Canon. For the application of the assets will be used the Concept TI Strill Monodose Fluid manufactured by Mezzo Dermocosmetics, registered in Anvisa nº 25351.379480 / 2018-17, composed by water, Edta, Hydroxyacetophenone, 1,2 - Hexanediol, Caprylyl Glycol, Disodium Edta, Glycine Soy Glycerin, Hydrogenated Lecithin, Citric Acid, Sh-Polypeptide-5, Butylene Glycol, Cetyl Hydroxyethylcellulose, Rutin, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, Phaseolus Lunatus Seed Extract, Bulbine Frutescens Leaf Juice, Bht. 5.3 PROCEDURE METHOD: During treatment the participants will be treated with fractional radiofrequency, G1 will be applied at 30-day intervals and subdivided into 2 GA groups. Abdomen with 8 patients and GB gluteal with 8 patients, the GA and GB groups were divided into 2 subgroups of 4 people each, 1 group with application of drugdelivery and 1 group without the application of drugdelivery. G2 will be applied at 15-day intervals and subdivided into 2 GC groups. Abdomen with 8 patients and gluteal GD with 8 patients, the GC and GD groups were divided into 2 subgroups of 4 people each, 1 drug application group and 1 group without the application of drug delivery. The drug consists of a solution rich in cell growth factors and the investigators will be applied after the intervention with Fractal Radiofrequency. The following modulation parameters will be used in the Fractional Radiofrequency equipment: Deep application mode, amplitude: 100% - ON time: 50 mseg - OFF time: 5 mseg - Pulsed mode - Pulse: 1mseg. In the gluteus and abdomen will be treated using - specific radiofrequency tips fractioned with the "fork" electrode (A distance between perforations of about 1 to 2 mm must be observed). The areas where the needle will penetrate will be cleaned with 70% alcohol before the procedure, the applications in the abdomen and gluteus will occur on the right side, the left side will not receive any radiofrequency treatment, being therefore used as a control, where later participants will be invited to treat the contralateral side. For the histological analysis, two patients from group G1 (abdomen and gluteus) and two patients from group G2 (abdomen and gluteus), a sample of the superficial tissue through a punch 3 mm in diameter, will be removed. The procedure will be under local anesthesia and performed by a medical plastic surgeon in order to minimize the risks.
  2. RISKS AND BENEFITS OF RESEARCH: The Radiofrequency apparatus is registered with ANVISA, the treatment is considered safe by the FDA and duly legalized its use in Brazil. Even if it is a new technique, the researchers will be assisted by a technician responsible for the machine during the entire treatment period to avoid any technical problem. The risks include the use of anticoagulants and liver problems (previously questioned in the initial interview with the patient during the first evaluation). If so, the participant will be excluded from the survey. Other risks are hyperemia of the skin due to the mechanism of application of the equipment that will be smoothed by the control and questioning at the beginning of the application and the patients must be with preserved sensitivity, by having the metal applicators, it can scratch, but this will be avoided with the inspection of the device before the application and with the speed of the moderate application, if it occurs the patient would receive all the necessary care and assistance to heal. The risk of burns will be reduced by controlling the temperature. For the patient submitted to punch the risk is scar formation and fibrosis in the area where the skin fragment will be collected, but in order to avoid these complications the removed fragment will have the smallest possible size so that it is minimally perceptible and the procedure will be performed by physician. In the event of any complications, we will provide the necessary assistance, including coverage of expenses, compensation for any damages resulting from research procedures, duly substantiated by specific consultations and examinations. The benefits of this research are related to the improvement of the striae in the treated region. As the literature cites, as well as increasing self-esteem of it.
  3. DATA ANALYSIS: After histological study, a statistical analysis will be performed to compare the degree of organization of the collagen and elastic fibers between the different treatment groups. A descriptive and inferential statistical analysis of the data will be performed through SPSS 19.0 (StatisticalPackage for the Social Science - Version 19.0). The normality of the date will be observed by the Kolmogorov - Smirnov (KS) test. For the comparison between groups whose parametric form data will be applied the one-way anova test for intergroup comparison. The significance level of 5% (p <0.05) will be adopted.
  4. EXPECTED RESULTS:

It is expected at the end of the study that the differentiated effects for conventional and Radiofrequency equipment in the dermal tissue will be demonstrated.

This study intends to evaluate the Fractional Radiofrequency effects as well as the parameters to be used, seeking to confirm what the literature cites in relation to its physiological effects. A more detailed analysis of the whole process after the application is sought, not yet clearly described by scientific studies.

Fractional Radiofrequency is expected to increase the increase of collagen fibers, preventing the process of natural skin aging and improving the appearance of stretch marks.

Conditions
Stretch Marks
Being tested
Fractitional Radiofrecuency with Drug Delivery, Fractitional Radiofrecuency
Keywords
Stretch Marks, Skin Disease, Diathermy, Drug Delivery Systems
Medical subject headings
Striae Distensae, Skin Diseases, Fever

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fractitional Radiofrecuency with Drug DeliveryDevice

    Electromagnetic energy within the spectrum of radio frequencies applied to the skin whose purpose is to generate thermal effects and which will be complemented with a skin drug

  • Fractitional RadiofrecuencyDevice

    Electromagnetic energy within the spectrum of radio frequencies applied to the skin whose purpose is to generate thermal effects

Study groups in NCT03931525
Study groupRoleWhat they receive
Radiofrequency therapy with drug delivery 30 days intervalExperimentalGroup that will be treated with Fractional Radiofrequency plus a regerative drug at the Gluteus or Abdomen level during 4 sessions with an interval of 30 days.
Receives: Device: Fractitional Radiofrecuency with Drug Delivery
Radiofrequency Therapy without drug delivery 30 days intervalActive comparatorGroup that will be treated with Fractional Radiofrequency at the Gluteus or Abdomen level during 4 sessions with an interval of 30 days.
Receives: Device: Fractitional Radiofrecuency
Radiofrequency therapy with drug delivery 15 daysExperimentalGroup that will be treated with Fractional Radiofrequency plus a regerative drug at the Gluteus or Abdomen level during 4 sessions with an interval of 15 days.
Receives: Device: Fractitional Radiofrecuency with Drug Delivery
Radiofrequency therapy without drug delivery 15 daysActive comparatorGroup that will be treated with Fractional Radiofrequency at the Gluteus or Abdomen level during 4 sessions with an interval of 15 days.
Receives: Device: Fractitional Radiofrecuency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Histological changes in stretch marks

    Analysis with electronic microscopy of the percentage increase or decrease in the type and amount of collagen, as well as circulatory changes.

    Measured: a period of 30 days or 15 days post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2019
  2. Study start1 Jun 2019
  3. Primary completion1 Nov 2019
  4. Study completion1 May 2025 (estimated)

Why it stopped: Dissolution of the research team

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03931525
Sponsor's protocol ID
8042019
Acronym
FRF
Status last verified
Jun 2024
First submitted
25 Apr 2019
Last updated
17 Jun 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chandrashekar BS, Sriram R, Mysore R, Bhaskar S, Shetty A. Evaluation of microneedling fractional radiofrequency device for treatment of acne scars. J Cutan Aesthet Surg. 2014 Apr;7(2):93-7. doi: 10.4103/0974-2077.138328.

    PubMed 25136209
  • Fistonic I, Sorta Bilajac Turina I, Fistonic N, Marton I. Short time efficacy and safety of focused monopolar radiofrequency device for labial laxity improvement-noninvasive labia tissue tightening. A prospective cohort study. Lasers Surg Med. 2016 Mar;48(3):254-9. doi: 10.1002/lsm.22450. Epub 2016 Jan 8.

    PubMed 26748986
  • Gonzalez-Suarez A, Gutierrez-Herrera E, Berjano E, Jimenez Lozano JN, Franco W. Thermal and elastic response of subcutaneous tissue with different fibrous septa architectures to RF heating: numerical study. Lasers Surg Med. 2015 Feb;47(2):183-95. doi: 10.1002/lsm.22301. Epub 2015 Feb 4.

    PubMed 25651998
  • Jimenez Lozano JN, Vacas-Jacques P, Anderson RR, Franco W. Effect of fibrous septa in radiofrequency heating of cutaneous and subcutaneous tissues: computational study. Lasers Surg Med. 2013 Jul;45(5):326-38. doi: 10.1002/lsm.22146. Epub 2013 Jun 3.

    PubMed 23733512
  • Key DJ. A Preliminary Study of a Transdermal Radiofrequency Device for Body Slimming. J Drugs Dermatol. 2015 Nov;14(11):1272-8.

    PubMed 26580877
  • Caruth JC. Evaluation of the Safety and Efficacy of a Novel Radiofrequency Device for Vaginal Treatment. Surg Technol Int. 2018 Jun 1;32:145-149.

    PubMed 29791707
  • Le Louarn C. [Midface region: functional anatomy, ageing process, indications and concentric malar lift]. Ann Chir Plast Esthet. 2009 Oct;54(5):411-20. doi: 10.1016/j.anplas.2009.04.003. Epub 2009 Aug 19. French.

    PubMed 19695761
  • Sadick NS, Makino Y. Selective electro-thermolysis in aesthetic medicine: a review. Lasers Surg Med. 2004;34(2):91-7. doi: 10.1002/lsm.20013.

    PubMed 15004818
  • Weiss RA. Noninvasive radio frequency for skin tightening and body contouring. Semin Cutan Med Surg. 2013 Mar;32(1):9-17.

    PubMed 24049924
  • Casabona G et al. Radiofrequência ablativa fracionada: um estudo piloto com 20 casos para rejuvenescimento da pálpebra inferior. Surg Cosmet Dermatol 2014;6(1):505.

  • Crocco, E.I.; Mantovani, P. A.;Volpini, B.M.F. Em Busca Dos Tratamentos Para Striae Rubra E Striae Alba: O Desafio Do Dermatologista. Surgical & Cosmetic Dermatology, V.4, N.4, P.332-337, 2012.

Questions about this trial

What is this clinical trial studying?

A study testing Fractitional Radiofrecuency with Drug Delivery and Fractitional Radiofrecuency in people with Stretch Marks, run by Quiropraxia y Equilibrio at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 17 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Histological changes in stretch marks (time frame: a period of 30 days or 15 days post intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03931525, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in